Enhancement of DNA ligase I level by gemcitabine in human cancer cells

Clinical Cancer Research

Volumn 8, Issue 4, 2002, Pages 1189-1195

  Sun, Daekyu ^a   Urrabaz, Rheanna ^a   Kelly, Susan ^a   Nguyen, Myhanh ^a   Weitman, Steve ^a  

^a CTRC Institute for Drug Development   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTARABINE; CYTIDINE DERIVATIVE; DNA POLYMERASE; FLUOROURACIL; GEMCITABINE; HYDROXYUREA; NUCLEOSIDE DERIVATIVE; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; RIBONUCLEOTIDE REDUCTASE; THYMIDYLATE SYNTHASE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CELL CYCLE S PHASE; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; DNA REPLICATION; DNA STRAND BREAKAGE; DRUG ACTIVITY; DRUG MECHANISM; DRUG RESPONSE; DRUG TARGETING; ENZYME ACTIVATION; ENZYME ASSAY; ENZYME INHIBITION; HUMAN; HUMAN CELL; MITOSIS INHIBITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL LINE;

ANTIMETABOLITES, ANTINEOPLASTIC; BLOTTING, WESTERN; CELL CYCLE; CYTARABINE; DEOXYCYTIDINE; DNA LIGASES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; FLUOROURACIL; HUMANS; HYDROXYUREA; TUMOR CELLS, CULTURED;

EID: 0036554931     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Hertel, L., Kroin, J. S., Misner, J. W., and Tustin, J. M. Synthesis of 2-deoxy-2,2-difluoro-D-ribose and 2-deoxy-2,2-difluoro-D-ribofuranosyl nucleotides. J. Org. Chem., 53: 2406-2409, 1988.
2. Abbruzzese, J. L. Phase I studies with the novel nucleoside analog gemcitabine. Semin. Oncol., 23: 25-31, 1996.
3. Hui, Y. F., and Reitz, J. Gemcitabine: a cytidine analogue active against solid tumors. Am. J. Health Syst. Pharm., 54: 162-170, 1997.
4. Carmichael, J., and Walling, J. Phase II activity of gemcitabine in advanced breast cancer. Semin. Oncol., 23: 77-81, 1996.
5. Gandhi, V., Mineishi, S., Huang, P., Yang, Y., Chubb, S., Chapman, A. J., Nowak, B. J., Hertel, L. W., and Plunkett, W. Difluorodeoxyguanosine: cytotoxicity, metabolism, and actions on DNA synthesis in human leukemia cells. Semin. Oncol., 22: 61-67, 1995.
6. Plunkett, W., Huang, P., Searcy, C. E., and Gandhi, V. Gemcitabine: preclinical pharmacology and mechanisms of action. Semin. Oncol., 23: 3-15, 1996.
7. Huang, P., Chubb, S., Hertel, L. W., Grindey, G. B., and Plunkett, W. Action of 2′,2′-difluorodeoxycytidine on DNA synthesis. Cancer Res., 51: 6110-6117, 1991.
8. Lindahl, T., and Branes, D. E. Mammalian DNA ligases. Annu. Rev. Biochem., 269, 251-281, 1992.
9. Tomkinson, A. E., Chen, J., Besterman, J., and Husain, I. Cellular functions of mammalian DNA ligases. In: J. A. Nickoloff and M. F. Hoekstra (eds.), DNA Damage and Repair, Vol. II: DNA Repair in Higher Eukaryotes, pp 181-198. Totowa, NJ: Humana Press, 1998.
10. Soderhall, S., and Lindahl, T. Mammalian DNA ligases. Serological evidence for two separate enzymes. J. Biol. Chem., 250: 8438-8444, 1975.
11. Chen, J., Tomkinson, A. E., Ramos, W., Mackey, Z. B., Danehower, S., Walter, C. A., Schultz, R. A., Besterman, J. M., and Husain, I. Mammalian DNA ligase III: molecular cloning, chromosomal localization, and expression in spermatocytes undergoing meiotic recombination. Mol. Cell. Biol., 15: 5412-5422, 1995.
12. Robins, P., and Lindahl, T. DNA ligase IV from HeLa cell nuclei. J. Biol. Chem., 271: 24257-24261, 1996.
13. Grawunder, U., Zimmer, D., Fugmann, S., Schwarz, K., and Lieber, M. R. DNA ligase IV is essential for V(D)J recombination and DNA double-stranded break repair in human precursor lymphocytes. Mol. Cell, 2: 477-484, 1998.
14. Wei, Y. F., Robins, P., Carter, K., Caldecott, K., Pappin, D. J., Yu, G. L., Wang, R. P., Shell, B. K., Nash, R. A., Schar, P., Barnes, D. E., Haseltine, W. A., and Lindahl, T. Molecular cloning and expression of human cDNAs encoding a novel DNA ligase IV and DNA ligase III, an enzyme active in DNA repair and recombination. Mol. Cell. Biol., 15: 3206-3216, 1995.
15. Congjun, L., Goodchild, J., and Baril, E. F. DNA ligase I is associated with 21S complex of enzymes for DNA synthesis in HeLa cells. Nucleic Acid Res., 22: 632-638, 1994.
16. Waga, S., Bauer, G., and Stillman, B. Reconstitution of complete SV40 DNA replication with purified replication factor. J. Biol. Chem., 269: 10923-10934, 1997.
17. Prigent, C., Satoh, M. S., Daly, G., Barnes, D. E., and Lindahl, T. Aberrant DNA repair and DNA replication due to an inherited enzymatic defect in human DNA ligase I. Mol. Cell. Biol., 14: 310-317, 1994.
18. Barnes, D. E., Tomkinson, A. E., Lehmann, A. R., Webster, A. D. B., and Lindahl, T. Mutations in the DNA ligase I gene of an individual with immunodeficiencies and cellular hypersensitivity to DNA-damaging agents. Cell, 69: 495-503, 1992.
19. Araujo, S. J., Tirode, F., Coin, F., Pospiech, H., Syvaoja, J. E., Stucki, M., Hubscher, U., Egly, J. M., and Wood, R. D. Nucleotide excision repair of DNA with recombinant human proteins: definition of the minimal set of factors, active forms of TFIIH, and modulation by CAK. Genes Dev., 1: 349-359, 2000.
20. Soderhall, S. DNA ligases during rat liver regeneration. Nature (Lond.), 260: 640-642, 1976.
21. Montecucco, A., Biamonti, G., Savini, E., Focher, F., Spadari, S., and Ciarrocchi, G. DNA ligase I gene expression during differentiation and cell proliferation. Nucleic Acids Res., 20: 6209-6214, 1992.
22. Teraoka, H., Sawai, M., Yamamoto, K., and Tsukada, K. DNA ligase I mRNA and enzyme levels in human hematopoietic cells under dimethyl sulfoxide-induced growth-arrest and differentiation. Biochem. Int., 26: 963-971, 1992.
23. Crul, M., Schellens, J. H., Beijnen, J. H., and Maliepaard, M. Cisplatin resistance and DNA repair. Cancer Treat. Rev., 23: 341-366, 1997.
24. Zamble, D. B., and Lippard, S. J. Cisplatin and DNA. repair in cancer chemotherapy. Trends Biochem. Sci., 20: 435-439, 1995.
25. Ali-Osman, F., Berger, M. S., Rairkar, A., and Stein, D. E. Enhanced repair of a cisplatin-damaged reporter chloramphenicol-O-acetyltransferase gene and altered activities of DNA polymerases α and β, and DNA ligase in cells of a human malignant glioma following in vivo cisplatin therapy. J. Cell Biochem., 54: 11-19, 1994.
26. Montecucco, A., Savini, E., Biamonti, G., Stefanini, M., Focher, F., and Ciarrocchi, G. Late induction of human DNA ligase I after UV-C irradiation. Nucleic Acids Res., 23: 962-966, 1995.
27. Ostruszka, L. J., and Shewach, D. S. The role of cell cycle progression in radiosensitization by 2′,2′-difluoro-2′-deoxycytidine. Cancer Res., 60: 6080-6088, 2000.
28. Rossi, R., Villa, A., Negri, C., Scovassi, I., Ciarrocchi, G., Biamonti, G., and Montecucco, A. The replication factory targeting sequence/PCNA-binding site is required in G(I) to control the phosphorylation status of DNA ligase I. EMBO J., 18: 5745-5754, 1999.
29. Fram, R. J., and Kufe, D. W. DNA strand breaks caused by inhibitors of DNA synthesis: 1-β-D-arabinofuranosylcytosine and aphidicolin. Cancer Res., 42: 4050-4053, 1982.
30. Slamenova, D., Gabelova, A., Ruzekova, L., Chalupa, I., Horvathova, E., Farkasova, T., Bozsakyova, E., and Stetina, R. Detection of MNNG-induced DNA lesions in mammalian cells; validation of comet assay against DNA unwinding technique, alkaline elution of DNA and chromosomal aberrations. Mutat. Res., 383: 243-252, 1997.
31. Panadero, A., Yin, M. B., Voigt, W., and Rustum, Y. M. Contrasting patterns of DNA fragmentation induced by thymidylate synthase inhibitors, ZD1694 and AG-331. Oncol. Res., 7: 73-81, 1995.